Clinical Pharmacokinetics

, Volume 2, Issue 6, pp 457–459 | Cite as

Current Literature References on Clinical Pharmacokinetics



Clinical Pharmacokinetic Essential Tremor Disopyramide Penicillin Versus South African Medical Journal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. The bioavailability of oral penicillin V. A comparative study of the absorption of different salts of penicillin V in children. Bolme, P. and Eriksson, M.: Acta Paediatrica Scandinavica 65: 253 (1976).PubMedCrossRefGoogle Scholar
  2. Urinary excretion of phenobarbital in a neonate having withdrawal symptoms. Hill, R.M.; Vernlaud, W.M.; Morgan, N.F. et al.: American Journal of Diseases of Children 131: 546 (1977).PubMedGoogle Scholar
  3. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Nilsson, S.; Nygren, K.G. and Johnasson, E.D.B.: American Journal of Obstetrics and Gynecology 129: 178 (1977).PubMedGoogle Scholar
  4. Relationship between age and tricyclic antidepressant plasma levels. Nies, A.; Robinson, D.S.; Friedman, M.J. et al.: American Journal of Psychiatry 134: 790 (1977).PubMedGoogle Scholar
  5. Guidelines for drug therapy in renal failure. Bennett, W.M.; Singer, I.; Golper, T. et al.: Annals of Internal Medicine 86: 754 (1977).PubMedGoogle Scholar
  6. Antibiotic concentrations of ascitic fluid of patients with ascites and bacterial peritonitis. Gerding, D.N.; Hall, W.H. and Schierl, E.A.: Annals of Internal Medicine 86: 708 (1977).PubMedGoogle Scholar
  7. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Szeto, H.H.; Inturrisi, C.E.; Houde, R. et al.: Annals of Internal Medicine 86: 738 (1977).PubMedGoogle Scholar
  8. Suppression of essential tremor by propranolol; correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. McAllister, R.G.; Markesbery, W.R.; Ware, R.W. et al.: Annals of Neurology 1: 160 (1977).PubMedCrossRefGoogle Scholar
  9. Efficacy of intravenous phenytoin in the treatment of status epilepticus: kinetics of central nervous system in penetration. Wilder, B.J.; Ramsay, R.E.; Willmore, L.J. et al.: Annals of Neurology 1: 511 (1977).PubMedCrossRefGoogle Scholar
  10. Tobramycin: maternal-fetal pharmacology. Bernard, Betty; Garcia-Cazares, S.J.; Ballard, C.A. et al.: Antimicrobial Agents and Chemotherapy 11: 688 (1977).PubMedCrossRefGoogle Scholar
  11. Maternal-fetal pharmacology of cefatrizine in the first 20 weeks of pregnancy. Bernard, Betty.; Thielen, P.; Garcia-Cazares, S.J. et al.: Antimicrobial Agentsand Chemotherapy 12: 231 (1977).CrossRefGoogle Scholar
  12. Distribution of amikacin in serum, muscle, and fat in children after a single intramuscular injection. Daschner, F.; Reiss, E. and Engert, J.: Antimicrobial Agents and Chemotherapy 11: 1081 (1977).PubMedCrossRefGoogle Scholar
  13. Pharmacokinetics of nafcillin in patients with renal failure. Diaz, C.R.; Kane, JG.; Parker, R.H. et al.: Antimicrobial Agents and Chemotherapy 12: 98 (1977).PubMedCrossRefGoogle Scholar
  14. Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants. Myers, M.G.; Roberts, R.J. and Mirhij, N.J.: Antimicrobial Agents and Chemotherapy 11: 1027 (1977).PubMedCrossRefGoogle Scholar
  15. Penetration of cefamandole into spinal fluid. Steinberg, E.A.; Overturf, G.D.; Baraff, L.J. et al.: Antimicrobial Agents and Chemotherapy 11: 933 (1977).PubMedCrossRefGoogle Scholar
  16. Elimination of pethidine and bupivacaine in the newborn. Cooper, L.V.; Stephen, G.W. and Aggett, P.J.A.: Archives of Disease in Childhood 52: 638 (1977).PubMedCrossRefGoogle Scholar
  17. A comparison study of amitriptyline and nortriptyline with plasma levels. Ziegler, V.E.; Clayton, P.J. and Biggs, J.T.: Archives of General Psychiatry 34: 607 (1977).PubMedCrossRefGoogle Scholar
  18. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis: Relationship of serum gold levels to therapeutic response. Sharp, J.T.; Lidsky, N.D.; Duffy, J. et al.: Arthritis and Rheumatism 20: 1179 (1977).PubMedCrossRefGoogle Scholar
  19. Spironolactone metabolism in normal subjects and in patients with liver cirrhosis. Varadi, A.; Feher, T.; Bodrogi, L. et al.: Arzneimittel-Forschung 27: 1618 (1977).PubMedGoogle Scholar
  20. Heparin pharmacokinetics: a model for precise anticoagulation. 12th Annual Meeting of Australasian Society of Nephrology, Cnristchurch, N.Z., 29th Sept., 1976. Farrell, P.C. and Gotch, F.A.: Aust. NZ J. Med 7: 215 (1977).Google Scholar
  21. Pharmacogenetic aspect of red blood cell lithium index in manic-depressive psychosis. Rybakowski, Janusz: Biological Psychiatry 12: 425 (1977).PubMedGoogle Scholar
  22. Urinary excretion and metabolism of pethidine and norpethidine in the newborn. Hogg, M.I.J.; Wiener, P.C.; Rosen, M. et al.: British Journal of Anaesthesia 49: 891 (1977).PubMedCrossRefGoogle Scholar
  23. Plasma metoprolo! concentrations in young, old and hypertensive subjects. Kendall, M.J.; Brown, Deirdre and Yates, R.A.: British Journal of Clinical Pharmacology 4: 497 (1977).PubMedCrossRefGoogle Scholar
  24. Lignocaine kinetics in cardiac patients and aged subjects. Nation, R.L.; Triggs, E.J. and Selig, M.: British Journal of Clinical Pharmacology 4: 439 (1977).PubMedCrossRefGoogle Scholar
  25. Drug metabolism in the elderly. Smithard, D.J. and Langman, M.J.S.: British Medical Journal 2: 520 (1977).PubMedCrossRefGoogle Scholar
  26. Plasma drug levels in once-daily dosage. Stevenson, I.H. and Schiff, A.A.: British Medical Journal 2: 579 (1977).PubMedCrossRefGoogle Scholar
  27. Co-trimoxazole plasma levels in subjects with liver failure. Angelucci, L.; Baldieri, M.; Barba, C. et al.: La Clinica Terapeutica 81: 111 (1977).PubMedGoogle Scholar
  28. The pharmacokinetics of salicylate in patients with rheumatoid arthritis. Proceedings of Australasian Society of Clinical and Experimental Pharmacologists 9th Annual Meeting, 27–28 Nov, 1975. Melbourne, Graham, G.; Champion, G.D.; Day, R.O. et al.: Clinical and Experimental Pharmacology and Physiology 4: 214 (1977).Google Scholar
  29. Plasma anticonvulsant concentration during pregnancy. Proceedings of Australasian Society of Clinical and Experimental Pharmacologists 9th Annual Meeting, 27–28 Nov, 1975, Melbourne, Lander, C.M.; Eadie, M.J. and Edwards, V.E.: Clinical and Experimental Pharmacology and Physiology 4: 218 (1977).Google Scholar
  30. Absorption of vitamin A in patients with cystic fibrosis. Absorption is best with emulsified vitamin A alcohol, Warwick, W.J.; Hansen, L.G. and Sharp, H.: Clinical Pediatrics 15: 807 (1976).PubMedCrossRefGoogle Scholar
  31. Protein binding of antimicrobials: Clinical pharmacokinetic and therapeutic implications. Craig, W.A. and Welling P.G.: Clinical Pharmacokinetics 2: 252 (1977).PubMedCrossRefGoogle Scholar
  32. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide. Cunningham, J.L.; Shen, D.D.; Shudo, I. and Azarnoff, D.L.: Clinical Pharmacokinetics 2: 373 (1977).PubMedCrossRefGoogle Scholar
  33. Prediction of digoxin dose requirements. Dobbs, S.M. and Mawer, G.E.: Clinical Pharmacokinetics 2: 281 (1977).PubMedCrossRefGoogle Scholar
  34. Pharmacokinetics of intravenous anaesthetics: implications for clinical use. Ghoneim, M.M. and Korttila, K.: Clinical Pharmacokinetics 2: 344 (1977)PubMedCrossRefGoogle Scholar
  35. Plasma level monitoring of tricyclic antidepressant therapy. Gram, L.F.: Clinical Pharmacokinetics 2: 237 (1977).PubMedCrossRefGoogle Scholar
  36. Antacid therapy and drug kinetics. Hurwitz, A.: Clinical Pharmacokinetics 2: 269 (1977).PubMedCrossRefGoogle Scholar
  37. Clinical pharmacokinetics of digitoxin. Perrier, D.; Mayersohn, M. and Marcus, F.I.: Clinical Pharmacokinetics 2: 292 (1977).PubMedCrossRefGoogle Scholar
  38. Clinical pharmacokinetics of hydralazine. Talseth, T.: Clinical Pharmacokinetics 2: 317 (1977).PubMedCrossRefGoogle Scholar
  39. Clinical pharmacokinetics of muscle relaxants. Wingard, L.B. and Cook, D.R.: Clinical Pharmacokinetics 2: 330 (1977).PubMedCrossRefGoogle Scholar
  40. Kinetics of primidone metabolism and excretion in children. Kauffman, RE.; Habersang, R. and Lansky, L.: Clinical Pharmacology and Therapeutics 22: 200 (1977).PubMedGoogle Scholar
  41. Antimicrobials when kidneys can’t cope. Ziment, I. and Koppel. M.H.J.: Current Prescribing p32 (1976).Google Scholar
  42. Pharmacokinetics of amikacin during hemo- and peritoneal dialysis. Regeur, L.; Colding, H.; Jensen, H. et al.: Danish Medical Bulletin 24: 122 (1977).Google Scholar
  43. Individual variation in the response to phenprocoumon. Husted, S. and Andreasen, F.: European Journal of Clinical Pharmacology 11: 351 (1977).PubMedCrossRefGoogle Scholar
  44. Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn’s disease. Melander, A.; Kahlmeter, G.; Kamme, C. et al.: European Journal of Clinical Pharmacology 12: 69 (1977).PubMedCrossRefGoogle Scholar
  45. The effect of renal failure on the disposition and neuromuscular blocking action of pancurnoium bromide. Somogyi, A.A.; Shanks, C.A. and Triggs, E.J.: European Journal of Clinical Pharmacology 12: 23 (1977).PubMedCrossRefGoogle Scholar
  46. Distribution and elimination of digoxin in infants. Wettrell, G.: European Journal of Clinical Pharmacology 11: 329 (1977).PubMedCrossRefGoogle Scholar
  47. Evidence of higher ethynylestradiol blood levels in human hypertensive oral contraceptive users. Ahluwalia, B.S.; Curry, C.L.; Crocker, C.L. et al.: Fertility and Sterility 28: 627 (1977).PubMedGoogle Scholar
  48. Digitalis bioavailability and elderly — metabolism of aged. Curri, G.; Tamburrini, L.R.; Giansante, C. et al.: Giornale di Gerontologia 25: 155 (1977).Google Scholar
  49. Observation on amoxicillin and ampicillin levels in sputum and relationship between sputum and serum levels of these antibiotics. Hada, M.: Japanese Journal of Antibiotics 30: 450 (1977).PubMedCrossRefGoogle Scholar
  50. Evaluation of intravenous injection of cephalothin in children. On the serum level of cephalothin during cardiac catheterization, Sunagawa, K.; Hara, N.; Nanri, S. et al.: Japanese Journal of Antibiotics 30: 459 (1977).PubMedGoogle Scholar
  51. Variation in theophylline clearance rate with time in chronic childhood asthma. Leung, P.; Kalisker, A. and Bell, T.D.: Journal of Allergy and Clinical Immunology 59: 440 (1977).PubMedCrossRefGoogle Scholar
  52. Breast milk distribution of theobromine from chocolate. Resman, Beth, H.; Blumenthal, H.P. and Jusko, W.J.: Journal of Pediatrics 91: 477 (1977).PubMedCrossRefGoogle Scholar
  53. Paradoxical behaviour of serum digoxin concentrations in an anuric neonate. Szefler, S.J.; Koup, J.R. and Clacoia, G.P.: Journal of Pediatrics 91: 487 (1977).PubMedCrossRefGoogle Scholar
  54. Clinical pharmacology and hexachlorophene in newborn infants. Tyrala, Eileen E.; Hillman, Laura, S.; Hillman, RE. et al.: Journal of Pediatrics 91: 481 (1977).PubMedCrossRefGoogle Scholar
  55. Intestinal absorption of digoxin in systemic sclerosis. Brachtel, R. and Gilfrich, H.J.: Klinische Wochenschrift 55: 439 (1977).PubMedCrossRefGoogle Scholar
  56. Serum concentrations of penicillin V in children after peroral administration in two forms, fasting and at mealtimes. Perlhagen, J.; Eden, T. and Lindstrom, D.: Lakartidningen 74: 2443 (1977).PubMedGoogle Scholar
  57. Use of prazosin at the Dunedin Hypertension Clinic: controlled and open studies and pharmacokinetic observations. Symposium on prazosin and hypertension, Sydney, Melbourne and Auckland, Feb/Mar 1977. Simpson, F.O.; Bolli, P. and Wood, A.J.: Medical Journal of Australia 2: 17 (1977).PubMedGoogle Scholar
  58. Tetracycline levels in the sputum in chronic obstructive bronchitis. Zimmerman, I.; Ulmer, W.T. and Ritzerfeld, W.: Munchener Medizinische Wochenschrift 119: 845 (1977).Google Scholar
  59. Intoxication with primidone: continuous monitoring of serum primidone and its metabolites during forced diuresis. Lagenstein, I.; Sternowsky, H.J.; Iffland, E. et al.: Neuropediatrie 8: 190 (1977).CrossRefGoogle Scholar
  60. Propranolol for thyroid storm. Hellman, R.; Kelly, K.L. and Mason, W.D.: N. Engl. J. Med 297: 672 (1977).Google Scholar
  61. Evaluation of penicillin in children with purulent meningitis. Hieber, J.P. and Nelson, J.D.: N. Engl. J. Med 297: 410 (1977).PubMedCrossRefGoogle Scholar
  62. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. Stoller, R.G.; Hande, K.R.; Jacobs, S.A. et al.: New England Journal of Medicine 297: 630 (1977).PubMedCrossRefGoogle Scholar
  63. Amikacin therapy of exacerbations of Pseudomoiias aeruginosa infections in patients wtih cystic fibrosis. Leu, W.K.; Young, L.S.; Osher, A.B. et al.: Pediatrics 60: 372 (1977).Google Scholar
  64. Clinical pharmacokinetics of atenolol. McAinsh, J.: Postgraduate Medical Journal 53: 74 (1977).PubMedGoogle Scholar
  65. Serum levels of isoniazid in patients with tuberculosis. Meierg, N.; Pierartf, O.; Kuhno, S. et al.: Rev. Med. Chil. 105: 390 (1977).Google Scholar
  66. The pharmacokinetics of cephaloridine (Ceporin) with special reference to its transplacental activity. Possible use in premature rupture of the membrane, Leng, B.M.; Leng, J.J.; Lesgouarres, M.T. et al.: Revue Francaise de Gynecologie et d’Obstetrique 72: 397–402 (1977).Google Scholar
  67. The binding of antituberculous drugs to normal and kwashiorkor serum. Buchanan, N. and van der Walt, L.A.: South African Medical Journal 52: 522 (1977).PubMedGoogle Scholar
  68. The binding of phenobarbitone and phenytoin to kwashiorkor serum. Buchanan, N. and van der Walt, L.A.: South African Medical Journal 52: 518 (1977).PubMedGoogle Scholar
  69. Thiopentone binding to kwashiorkor serum. S.A. Pharmacological Society and Physiological Society of Southern Africa, Buchanan, N. and van der Walt, L.A.: South African Medical Journal 52: 371 (1977).Google Scholar
  70. The metabolism of phenobarbitone, phenytoin and antipyrine in black patients. Buchanan, N.; Bill, P.; Moodley, G. et al.: South African Medical Journal 52: 394 (1977).PubMedGoogle Scholar
  71. Drug therapy, serum levels and haematological sequelae in 100 adult epileptics. S.A. Pharmacological Society and Physiological Society of Southern African. Buchanan, N.; Bill, P.; Strick-wood, B. et al.: South African Medical Journal 52: 410 (1977).Google Scholar
  72. Long-term therapy with phenobarbitone and phenytoin in blacks — serum levels and other laboratory parameters. S.A. Pharmacological Society and Physiological Society of Southern Africa. Gosling, J.A.; Hundt, H.K.L.; Aucamp, A.K. et al.: South African Medical Journal 52: 371 (1977).Google Scholar

Copyright information

© ADIS Press 1977

Personalised recommendations